Search

everythinglearnresearchcommunity

for

Search:↓

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Cancer risk is linked to the balance of mutations and environmental factors, not just the number of mutations.

Implementing safety strategies is crucial to prevent radiation-related health issues.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Hair keratin treatments can be harmful, potentially causing health issues like skin reactions and cancer.

Baldness may lower the risk of testicular cancer.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

Cancer patients with COVID-19 face higher risks due to possible additional infections.

The link between anabolic agents and colorectal cancer risk is unclear.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Childhood and adult height, and early immune-related hospitalizations increase testicular cancer risk, while baldness, larger families, and sports reduce it.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Finasteride significantly reduces prostate cancer risk.

Finasteride reduces prostate cancer risk but may increase high-grade cancer risk.

Finasteride reduces prostate cancer risk but may increase aggressive cancer risk slightly.

Zinc deficiency increases stomach cancer risk and causes health issues in rats.

Finasteride lowers prostate cancer risk but may increase high-grade tumors and sexual side effects.

Finasteride may reduce prostate cancer risk.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Infertile men are more likely to produce sperm with abnormal chromosome numbers, which can affect pregnancy success and embryo health.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Finasteride significantly reduces the risk of prostate cancer.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.